S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:GSTC

GlobeStar Therapeutics (GSTC) Stock Price, News & Analysis

$0.0009
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$0.0007
$0.0015
50-Day Range
N/A
52-Week Range
$0.0007
$0.01
Volume
56.60 million shs
Average Volume
13.01 million shs
Market Capitalization
$1.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GSTC stock logo

About GlobeStar Therapeutics Stock (OTCMKTS:GSTC)

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.

GSTC Stock Price History

GSTC Stock News Headlines

Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
KHTRF Knight Therapeutics Inc.
GlobeStar Therapeutics Corp GSTC
Penny Stocks On The Move: HALB, NHMD, IFUS, GSTC
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
GlobeStar Therapeutics Corporation (GSTC)
GlobeStar Therapeutics Corp
GlobeStar Therapeutics Corp (GSTC)
See More Headlines
Receive GSTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlobeStar Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/29/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:GSTC
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Net Income
$-1,950,000.00
Pretax Margin
N/A
Return on Assets
-75,007.21%

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Outstanding Shares
1,162,921,000
Free Float
1,133,848,000
Market Cap
$1.05 million
Optionable
Not Optionable
Beta
1.55
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. James C. Katzaroff (Age 67)
    President, CEO, Secretary, Principal Executive Officer & Chairman of the Board
    Comp: $180k
  • Mr. Robert R. Hale Chicoski CPA (Age 81)
    CFO, Treasurer, Secretary, Principal Financial & Accounting Officer
    Comp: $84k
  • Ms. Brooke Greenwald
    Chief Marketing Officer
  • Mr. David Croom
    Executive Vice President

GSTC Stock Analysis - Frequently Asked Questions

How have GSTC shares performed in 2024?

GlobeStar Therapeutics' stock was trading at $0.0009 at the start of the year. Since then, GSTC stock has increased by 0.0% and is now trading at $0.0009.
View the best growth stocks for 2024 here
.

Are investors shorting GlobeStar Therapeutics?

GlobeStar Therapeutics saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 243,700 shares, an increase of 24,270.0% from the February 29th total of 1,000 shares. Based on an average daily volume of 8,486,800 shares, the short-interest ratio is currently 0.0 days.
View GlobeStar Therapeutics' Short Interest
.

How do I buy shares of GlobeStar Therapeutics?

Shares of GSTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GSTC) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners